In melanoma, O’Connell et al. initially observed opposing roles for ROR1 and ROR2: melanoma cell lines resistant to inhibition of the serine/threonine-protein kinase B-raf (BRAF) were characterized by upregulated ROR2, but downregulated ROR1 [103]. The gene discussed is BRAF; the disease is melanoma.